The Prostatic Urethral Lift for the Treatment of Lower Urinary Tract Symptoms Associated with Prostate Enlargement Due to Benign Prostatic Hyperplasia: The L.I.F.T. Study
Abstract
Purpose:
We report the first multicenter randomized blinded trial of the prostatic urethral lift for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Materials and Methods:
Men at least 50 years old with AUASI (American Urological Association Symptom Index) 13 or greater, a maximum flow rate 12 ml per second or less and a prostate 30 to 80 cc were randomized 2:1 between prostatic urethral lift and sham. In the prostatic urethral lift group small permanent implants are placed within the prostate to retract encroaching lobes and open the prostatic urethra. Sham entailed rigid cystoscopy with sounds mimicking the prostatic urethral lift. The primary end point was comparison of AUASI reduction at 3 months. The prostatic urethral lift arm subjects were followed to 1 year and assessed for lower urinary tract symptoms, peak urinary flow rate, quality of life and sexual function.
Results:
A total of 206 men were randomized (prostatic urethral lift 140 vs sham 66). The prostatic urethral lift and sham AUASI was reduced by 11.1 ± 7.67 and 5.9 ± 7.66, respectively (p = 0.003), thus meeting the primary end point. Prostatic urethral lift subjects experienced AUASI reduction from 22.1 baseline to 18.0, 11.0 and 11.1 at 2 weeks, 3 months and 12 months, respectively, p <0.001. Peak urinary flow rate increased 4.4 ml per second at 3 months and was sustained at 4.0 ml per second at 12 months, p <0.001. Adverse events were typically mild and transient. There was no occurrence of de novo ejaculatory or erectile dysfunction.
Conclusions:
The prostatic urethral lift, reliably performed with the patient under local anesthesia, provides rapid and sustained improvement in symptoms and flow, while preserving sexual function.
References
- 1 : Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations. Rev Urol2008; 10: 14. Google Scholar
- 2 : Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph Project. Eur Urol2003; 58: 539. Google Scholar
- 3 Roehrborn CG, McConnell JD, Bary MJ et al: American Urological Association Guideline: Management of benign prostatic hyperplasia (BPH). American Urological Association Education and Research Inc. 2003. Google Scholar
- 4 McVary KT, Roehrborn CG, Avins AL et al: American Urological Association Guideline: Management of benign prostatic hyperplasia (BPH). American Urological Association Education and Research Inc. 2010. Google Scholar
- 5 : Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol2012; 62: 315. Google Scholar
- 6 : Minimally invasive prostatic urethral lift: surgical technique and multinational experience. Eur Urol2013; 64: 292. Google Scholar
- 7 : Safety and feasibility of the Prostatic Urethral Lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int2011; 108: 82. Google Scholar
- 8 : Prostatic Urethral Lift: two-year results after treatment for lower urinary symptoms secondary to benign prostatic hyperplasia. Urology2012; 79: 5. Google Scholar
- 9 : Preservation of sexual function with the Prostatic Urethral Lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Sex Med2012; 9: 368. Google Scholar
- 10 : UroLift system for the relief of prostate obstruction under local anesthesia. Can Urol2012; 19: 6217. Google Scholar
- 11 : Maximum urinary flow rate by uroflowmetry: automatic or visual interpretation. J Urol1993; 149: 339. Link, Google Scholar
- 12 : A sham controlled trial of transurethral microwave therapy with subsequent treatment of the control group. J Urol1994; 152: 453. Link, Google Scholar
- 13 : Transurethral microwave thermotherapy v sham treatment: double-blind randomized study. J Endourol1996; 10: 565. Google Scholar
- 14 : Longitudinal data analysis in medical device clinical studies. J Biopharm Stat2008; 18: 44. Google Scholar
- 15 : A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial. Urology1998; 51: 731. Google Scholar
- 16 : Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, multicenter, sham-controlled trial. Urology1998; 51: 19. Google Scholar
- 17 : Update on the sexual impact of treatment for benign prostatic hyperplasia. Curr Urol Rep2012; 13: 433. Google Scholar
- 18 : Relevance and variability of the severity of incontinence and increased daytime and night-time voiding frequency, associated with quality of life in men with lower urinary tract symptoms. BJU Int2005; 96: 83. Google Scholar
- 19 : How important are men’s lower urinary tract symptoms (LUTS) and their impact on the quality of life (QOL)?. Qual Life Res2005; 14: 1733. Google Scholar
- 20 : Waning sexual function–the most important disease-specific distress for patients with prostate cancer. Br J Cancer1996; 73: 1417. Google Scholar
- 21 : A cross-national study of subjective sexual well-being among older women and men: findings from the Global Study of Sexual Attitudes and Behaviors. Arch Sex Behav2006; 35: 145. Google Scholar
